Akuis builds connected robotic fitness and rehabilitation devices, with its flagship product Sintesi positioned for personal training studios, beauty centers and physiotherapy clinics. The company operates a B2B sales model, both direct and through distributors, and has sold over 600 Sintesi units worldwide. Akuis reports a team of 14 specialists and a compound annual growth rate of 65% since 2020. Financially the startup closed 2023 with €1.7M in revenue, a 25% increase over 2022, with half of revenues from foreign markets. Planned uses of new funding include market expansion (Spain, the Netherlands, Eastern Europe and Asia), obtaining US and medical certifications, industrializing new products and broadening the product offering. The company will also allocate 20% of the raised funds to continuous improvement of its hardware and software products. Akuis, founded in 2018 in Tolmezzo (Udine), develops Sintesi, a compact home-fitness device that leverages technologies from the aerospace sector and is protected by international patents. Sintesi pairs physical equipment with a digital platform that guides users step-by-step through exercises, records performance and improvements, and offers a virtual personal trainer to work on performance and motivation. The product is positioned for home fitness, boutique gyms and physiotherapists and is described as a full training platform rather than a single device. Akuis has a team of 11 people and reported an average growth rate of 357% in its first three years, with an expected growth rate of about 250% through 2024. Sintesi was named among the 20 most innovative products at FIBO2020 and Akuis was listed among the top four most promising startups worldwide. Management plans to use funding to continue product and software development, enable engagement and personalization initiatives, and support sustained market growth.

Total raised

$2M

Funding rounds

2

Latest round

Equity

Latest activity

Mar 2024